Cases of pneumonia detected in Wuhan, China were first reported to the WHO
On Dec. 31, 2019, the World Health Organization (WHO) declared the Coronavirus outbreak a global pandemic. To date,…
Sinovac announced approval of varicella vaccine for prevention of varicella/zoster virus (chickenpox) in children
On Dec. 27, 2019, Sinovac Biotech announced that the China National Medical Products Administration (NMPA) had approved and…
Medigen Vaccine Biologics completed enrollment of phase III MRCT For EV71 vaccine
On Dec. 25, 2019, Medigen Vaccine Biologics (MVB) announced it had completed the enrollment of phase III multi-region…
New MERS Coronavirus vaccine clinical trial started in Saudi Arabia
On Dec. 20, 2019, Vaccitech’s partner, the University of Oxford’s Jenner Institute, in collaboration with The King Abdullah…
Pediatric brain tumor treatment at the University of Alabama awarded FDA grant for first-in-human study
On Dec. 17, 2019, the University of Alabama at Birmingham Comprehensive Cancer Center (UAB) announced that Gregory Friedman,…
Ceres Nanosciences launched Nanotrap Virus Capture Kit
On Nov. 7, 2019, Ceres Nanosciences announced the commercial launch of the Nanotrap Virus Capture Kit. The Nanotrap…
Study highlighted Zika lessons, need to stay vigilant
On Oct. 18, 2019, in the New England Journal of Medicine, researchers published a comprehensive review of this…
FDA approved the JYNNEOS Vaccine for the prevention of smallpox and monkeypox
On Sept. 24, 2019, the U.S. Food and Drug Administration announced approval of Jynneos Smallpox and Monkeypox Vaccine,…
CDC published updated ACIP recommendations for human papillomavirus vaccination of adults
On Aug. 16, 2019, the Centers for Disease Control and Prevention (CDC) published updated Immunization Practices Advisory Committee…
Vanderbilt Vaccine Center Director James Crow Jr, MD, was awarded half of the Future Insight Prize by Merck KGaA of Germany
On Jul. 9, 2019, Vanderbilt Vaccine Center announced that Director James Crow Jr., MD, had been awarded half…
Chembio Diagnostics received CE Mark for point-of-care multiplex test for Zika, Dengue and Chikungunya
On Jun. 27, 2019, Chembio Diagnostics announced that is had obtained a CE mark for its DPP Zika/Dengue/Chikungunya…
the largest stock of the rinderpest virus was destroyed at the Pirbright Institute.
On Jun. 14, 2019, the Pirbright Institute announced that it had destroyed the last samples of rinderpest virus…
FDA authorized marketing of first diagnostic test for detecting Zika virus antibodies
On May 23, 2019, the U.S. Food and Drug Administration (FDA) announced that it had authorized InBios’ marketing…
UGA researchers discovered a vaccine for Crimean-Congo Hemorrhagic Fever (CCHF) virus
On Apr. 25, 2019, researchers at the University of Georgia announced they had successfully discovered a single-dose vaccine…
Sinovac announced positive results from phase III trial of a Sabin strain-based inactivated Polio vaccine (sIPV) were published
On Apr. 16, 2019, Sinovac Biotech announced that the positive results from the Company’s Phase III clinical study…
Chembio Diagnostics received approval of Zika, Dengue and Chikungunya point-of-care multiplex test by Brazil’s Health Regulatory Agency
On Apr. 9, 2019, Chembio Diagnostics announced the approval of its DPP Zika/Dengue/Chikungunya System by Agencia Nacional de…
FDA approved Vaxelis, a new combination DTaP-IPV-Hib-HepB vaccine for use in children 6 wks-4 yrs of age
On Dec. 26, 2018, Sanofi announced the U.S. Food and Drug Administration (FDA) had approved VAXELIS (Diphtheria and…
FDA approved expanded use of Gardasil 9 vaccine to include adults 27 through 45 years old
On Oct. 5, 2018, the FDA announced it had approved a supplemental application for Gardasil 9 (Human Papillomavirus…
Vaccitech licensed MERS rights to Oxford University
On Sept. 27, 2018, CEPI (the Coalition for Epidemic Preparedness Innovations) announced a collaboration with The Jenner Institute…
Diagnostics | Disease | FDA
InBios received FDA clearance for its DENV detect NS1 ELISA test for early detection of Dengue fever
On Sept. 11, 2018, the U.S. Food and Drug Administration (FDA) had announced that it had received 510k…
CDC published updated ACIP recommendations for prevention of hepatitis B virus infection
On Jan. 12, 2018, the U.S. Centers for Disease Control and Prevention (CDC) published updated Immunization Practices Advisory…
Canadian researchers reconstituted an extinct poxvirus using mail-order DNA
On Jul 6, 2017, a group led by virologist David Evans of the University of Alberta in Edmonton,…
HIV research cleared name of ‘Patient Zero,’ Gaetan Dugas
On Oct, 26, 2016, a team of researchers at the University of Arizona and University of Cambridge in…
Arbutus’ CSO, Dr. Michael J Sofia, awarded Lasker~DeBakey Clinical Medical Research Award
On Sept. 13, 2016, Arbutus Biopharma announced that Dr. Michael J. Sofia, Arbutus’ Chief Scientific Officer, had been…
InBios received FDA EUA for its ZIKV Detect IgM Capture ELISA diagnostic test for antibodies in human serum
On Aug. 19, 2016, InBios announced that it had received an Emergency Use Authorization (EUA) from the U.S….
The New England Primate Research Center closed its doors
On May 31, 2015, the New England Primate Research Center (NEPRC) closed its doors. During its five decades…
Biotechnology | Infectious Disease | Life Science News | Medicine | Non-Profit Research | Therapeutics
Alaskapox virus was first identified in a patient in Fairbanks
In 2015, the state of Alaska Department of Health announced they had identified Alaskapox virus in a patient…
FDA announced approval of peramivir (Rapivab) for treatment of uncomplicated influenza in adults
On Dec. 22, 2014, Sanofi Pasteur announced the FDA had approved the supplemental biologics license application (sBLA) for…
FDA approved the use of Gardasil 9 HPV vaccine in the US
On Dec. 11, 2014, Merck announced that the FDA had approved GARDASILï¾®9 (Human Papillomavirus 9-valent Vaccine, Recombinant), Merckï¾’s…
FDA approved quadrivalent formulation of Fluzone Intradermal inactivated influenza vaccine
On Dec. 12, 2014, Sanofi Pasteur announced the FDA had approved the supplemental biologics license application (sBLA) for…